Amanzio Martina, Palermo Sara
Department of Psychology, University of Turin, Turin, Italy.
European Innovation Partnership on Active and Healthy Ageing, Bruxelles, Belgium.
Front Pharmacol. 2019 Sep 2;10:969. doi: 10.3389/fphar.2019.00969. eCollection 2019.
The exacerbation of a clinical condition or the occurrence of negative symptoms after an inert substance dispensation or a sham treatment is known as "nocebo effect." Nocebo is the psychobiological effect due to the negative psychosocial context that accompanies a therapy, and it is a direct consequence of negative expectations by the patients and their own personal characteristics. Although the clinical relevance of the phenomenon is now recognized, a small number of studies have tried to ascertain its neural underpinnings (that it means nocebo responses). Moreover, there is no consensus on the brain networks involved in nocebo processes in humans. In particular, nocebo hyperalgesia has attracted almost no research attention. We conducted a mini-review on the few experimental pain functional magnetic resonance imaging (fMRI) studies of nocebo responses to discuss how negative expectancies and conditioning effects engage brain networks to modulate pain experiences. Moreover, we present possible clinical implications considering Alzheimer's disease and behavioral frontotemporal dementia, in which the existence of a hypothetically disrupted neurocognitive anticipatory network-secondary to an endogenous pain modulatory system damage-may be responsible for pain processing alterations.
在给予惰性物质或进行假治疗后,临床病情加重或出现负面症状,这被称为“反安慰剂效应”。反安慰剂效应是伴随治疗出现的负面心理社会背景所导致的心理生物学效应,它是患者负面期望及其个人特征的直接后果。尽管现在人们已经认识到这一现象的临床相关性,但只有少数研究试图确定其神经基础(即反安慰剂反应)。此外,对于人类反安慰剂过程中涉及的脑网络尚无共识。特别是,反安慰剂性痛觉过敏几乎没有引起研究关注。我们对少数关于反安慰剂反应的实验性疼痛功能磁共振成像(fMRI)研究进行了小型综述,以讨论负面预期和条件作用效应如何激活脑网络来调节疼痛体验。此外,我们考虑到阿尔茨海默病和行为性额颞叶痴呆,提出了可能的临床意义,在这些疾病中,假设由于内源性疼痛调节系统受损导致神经认知预期网络遭到破坏,这可能是疼痛处理改变的原因。